145
Views
28
CrossRef citations to date
0
Altmetric
Review

Zoledronic acid in the management of metastatic bone disease

, , , &
Pages 1333-1348 | Published online: 22 Nov 2006

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Giuseppe Tonini, Bruno Vincenzi & Daniele Santini. (2011) Bisphosphonate anticancer activity. Expert Opinion on Pharmacotherapy 12:5, pages 681-683.
Read now
Pete Anderson & Rodolfo Nuñez. (2007) Samarium lexidronam (153Sm-EDTMP): skeletal radiation for osteoblastic bone metastases and osteosarcoma. Expert Review of Anticancer Therapy 7:11, pages 1517-1527.
Read now

Articles from other publishers (26)

Carlo A. Mallio, Federico Greco, Francesco Gaudino, Bruno Beomonte Zobel & Carlo C. Quattrocchi. (2023) Computed tomography density changes of bone metastases after concomitant denosumab. Skeletal Radiology 52:8, pages 1567-1575.
Crossref
Junjie Lu, Desheng Hu, Yan Zhang, Chen Ma, Lin Shen & Bo Shuai. (2023) Current comprehensive understanding of denosumab (the RANKL neutralizing antibody) in the treatment of bone metastasis of malignant tumors, including pharmacological mechanism and clinical trials. Frontiers in Oncology 13.
Crossref
Mỹ-Vân Nguyễn, Christophe Carlier, Christophe Nich, François Gouin & Vincent Crenn. (2021) Fracture Risk of Long Bone Metastases: A Review of Current and New Decision-Making Tools for Prophylactic Surgery. Cancers 13:15, pages 3662.
Crossref
Daniel K. Partain & Mihir M. Kamdar. 2020. Spine Pain Care. Spine Pain Care 213 218 .
Kristen B. Farrell, Alexander Karpeisky, Douglas H. Thamm & Shawn Zinnen. (2018) Bisphosphonate conjugation for bone specific drug targeting. Bone Reports 9, pages 47-60.
Crossref
Daniel P. Milgrom, Neha L. Lad, Leonidas G. Koniaris & Teresa A. Zimmers. (2017) Bone Pain and Muscle Weakness in Cancer Patients. Current Osteoporosis Reports 15:2, pages 76-87.
Crossref
Hye-Yeon Kim, Jin-Woo Kim, Sun-Jong Kim, Sang-Hwa Lee & Hong-Soo Lee. (2017) Uncertainty of current algorithm for bisphosphonate-related osteonecrosis of the jaw in population-based studies: a systematic review. Journal of Bone and Mineral Research 32:3, pages 584-591.
Crossref
Wei-dong Zhang, Da-ren Liu, Cheng-cheng Feng, Chuan-biao Zhou, Chen-ni Zhan, Ri-sheng Que & Li Chen. (2014) Management of differentiated thyroid carcinoma with bone metastasis: a case report and review of the Chinese literature???????????????????????. Journal of Zhejiang University SCIENCE B 15:12, pages 1081-1087.
Crossref
Mehmet Ali AltayFerda TasarEmre TosunBahadir Kan. (2014) Low-Level Laser Therapy Supported Surgical Treatment of Bisphosphonate Related Osteonecrosis of Jaws: A Retrospective Analysis of 11 Cases. Photomedicine and Laser Surgery 32:8, pages 468-475.
Crossref
Howard S. Smith & Robert L. Barkin. (2014) Painful Boney Metastases. American Journal of Therapeutics 21:2, pages 106-130.
Crossref
Howard S. Smith & Intikhab Mohsin. (2013) Painful Boney Metastases. The Korean Journal of Pain 26:3, pages 223-241.
Crossref
Robert U. Ashford, Linus Benjamin, Susan Pendlebury & Paul D. Stalley. (2012) The modern surgical and non-surgical management of appendicular skeletal metastases. Orthopaedics and Trauma 26:3, pages 184-199.
Crossref
Paolo VescoviMaddalena ManfrediElisabetta MerigoRebecca GuidottiMarco MeletiGiuseppe PedrazziCarlo FornainiMauro BonaniniTeore FerriSamir Nammour. (2012) Early Surgical Laser-Assisted Management of Bisphosphonate-Related Osteonecrosis of the Jaws (BRONJ): A Retrospective Analysis of 101 Treated Sites with Long-Term Follow-Up. Photomedicine and Laser Surgery 30:1, pages 5-13.
Crossref
Daniele Santini, Maria Elisabetta Fratto & Matti Aapro. 2012. Prevention of Bone Metastases. Prevention of Bone Metastases 171 185 .
Yorihisa OritaIwao Sugitani, Kazuhisa Toda, Jun ManabeYoshihide Fujimoto. (2011) Zoledronic Acid in the Treatment of Bone Metastases from Differentiated Thyroid Carcinoma. Thyroid 21:1, pages 31-35.
Crossref
Dirk Rades, Steven E. Schild & Janet L. Abrahm. (2010) Treatment of painful bone metastases. Nature Reviews Clinical Oncology 7:4, pages 220-229.
Crossref
Yorihisa Orita, Iwao Sugitani, Masaaki Matsuura, Masaru Ushijima, Kiyoaki Tsukahara, Yoshihide Fujimoto & Kazuyoshi Kawabata. (2010) Prognostic factors and the therapeutic strategy for patients with bone metastasis from differentiated thyroid carcinoma. Surgery 147:3, pages 424-431.
Crossref
Konstantinos TziomalosVasilios G. AthyrosAsterios Karagiannis. (2009) Pharmacotherapy of Paget's Disease of Bone: Focus on Zoledronic Acid. Clinical Medicine. Therapeutics 1, pages CMT.S1095.
Crossref
E. P. Spugnini, B. Vincenzi, G. Caruso, A. Baldi, G. Citro, D. Santini & G. Tonini. (2009) Zoledronic acid for the treatment of appendicular osteosarcoma in a dog. Journal of Small Animal Practice 50:1, pages 44-46.
Crossref
Daniele Santini, Maria Elisabetta Fratto, Sara Galluzzo, Bruno Vincenzi & Giuseppe Tonini. (2009) Are bisphosphonates the suitable anticancer drugs for the elderly?. Critical Reviews in Oncology/Hematology 69:1, pages 83-94.
Crossref
Joseph Gligorov & Jean-Pierre Lotz. (2008) Optimal treatment strategies in postmenopausal women with hormone-receptor-positive and HER2-negative metastatic breast cancer. Breast Cancer Research and Treatment 112:S1, pages 53-66.
Crossref
Francesca M. Tumminello, Carla Flandina, Marilena Crescimanno & Gaetano Leto. (2008) Circulating cathepsin K and cystatin C in patients with cancer related bone disease: Clinical and therapeutic implications. Biomedicine & Pharmacotherapy 62:2, pages 130-135.
Crossref
Daniele Santini, Sara Galluzzo, Maria Elisabetta Fratto, Bruno Vincenzi, Silvia Angeletti, Giordano Dicuonzo, Gaia Schiavon & Giuseppe Tonini. (2008) Bisphosphonates: from preclinical evidence to survival data in the oncologic setting. Oncology Reviews 1:3, pages 141-151.
Crossref
Shafaat A. Rabbani & Andrew P. Mazar. (2007) Evaluating distant metastases in breast cancer: from biology to outcomes. Cancer and Metastasis Reviews 26:3-4, pages 663-674.
Crossref
D.B. Kimmel. (2016) Mechanism of Action, Pharmacokinetic and Pharmacodynamic Profile, and Clinical Applications of Nitrogen-containing Bisphosphonates. Journal of Dental Research 86:11, pages 1022-1033.
Crossref
D. Santini, S. Galluzzo, B. Vincenzi, G. Schiavon, E. Fratto, F. Pantano & G. Tonini. (2007) New developments of aminobisphosphonates: the double face of Janus. Annals of Oncology 18, pages vi164-vi167.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.